Remicade (infliximab) - J&J
Taltz (ixekizumab) - Eli Lilly
Bimzelx (bimekizumab-bkzx) - UCB
Cimzia (certolizumab pegol) - Astellas, UCB
Humira (adalimumab) - AbbVie
Tremfya (guselkumab) - J&J
methotrexate - Generic mfg.
Ilumya (tildrakizumab-asmn) - Sun Pharma, Almirall
Cosentyx (secukinumab) - Novartis
Stelara (ustekinumab) - J&J
cyclosporine - Generic mfg.
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Siliq (brodalumab) - Bausch Health
apremilast - Generic mfg.
Enbrel (etanercept) - Pfizer, Amgen
acitretin - Generic mfg.
http://www.ncbi.nlm.nih.gov/pubmed/41382734
 
Heber Rew Bright Bright; Mark Lunt; Richard B Warren; Zenas Z N Yiu
 
Dec 12, 2025
 
Next